[Federal Register Volume 66, Number 243 (Tuesday, December 18, 2001)]
[Notices]
[Page 65210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-31055]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Meeting of the Drug Control Research, Data, and Evaluation 
Committee

AGENCY: Office of National Drug Control Policy.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: ONDCP will convene a meeting of the Drug Control Research, 
Data, and Evaluation Advisory Committee on January 17-18, 2002, at the 
White House Conference Center located at 726 Jackson Place, NW., 
Washington, DC. The meeting will begin promptly each day at 9 am and 
adjourn at 4 pm. The agenda will include general discussion and briefs 
on national drug use indicators and other federal drug control 
initiatives including, but not limited to the following: (1) 
Interagency Oxycontin Work Group Progress Report on an Early Warning 
System for Pharmaceutical Diversion Abuse; (2) a Redesign Proposal for 
the Drug Abuse Warning Network (DAWN); (3) ONDCP's Anti-Drug Media 
Campaign Evaluation; (4) 2001 National Household Survey on Drug Abuse 
State Estimates of Treatment Need and Drug Use Prevalence; (5) The 
RAMONA Project (Random Access Monitoring of Narcotics Addicts); (6) 
HHS's Report on Closing the Drug Abuse Treatment Gap: A Report to the 
President of the U.S.; (7) Updates on Drug Free Communities Grant 
Program; and (8) Activities related to: prevention, families, schools, 
and workplaces. There will be an opportunity for public comment from 
11:30 am to 12 Noon on Thursday, January 17, 2002.

DATES: January 17-18, 2002, 9 am to 4:00 pm. Opportunity for public 
comment from 11:30 am to 12:00 noon on Thursday, January 17, 2002.

ADDRESSES: White House Conference Center, 726 Jackson Place, NW, 
Washington, DC.

FOR FURTHER INFORMATION CONTACT: Linda V. Priebe, Assistant General 
Counsel, Office of National Drug Control Policy, Washington, DC (202) 
395-6622.

    Dated: December 11, 2001.
Linda V. Priebe,
Assistant General Counsel.
[FR Doc. 01-31055 Filed 12-17-01; 8:45 am]
BILLING CODE 3180-02-P